Suit Over a Marker

Sep 08, 2009

A biotech company is suing a prostate cancer researcher for making false claims concerning a disease biomarker, reports Science Insider. According to the Pittsburgh Tribune-Review, Robert Getzenberg, then at University of Pittsburgh and now at Johns Hopkins University, he found a biomarker, EPCA-2, for human prostate cancer that he and the University of Pittsburgh patented it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Same Old Error

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

Own Merits

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Back to Neanderthals

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

PNAS Papers on Small Molecule From Soil Bacteria, Circulating Tumor Cell Chip, More

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.

Menu